REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Micurx Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Micurx Pharmaceutical Co., Ltd. Profile Updated: May 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai MicuRx Pharmaceutical Co., Ltd. is a biopharmaceutical company focusing on novel therapeutics for infectious diseases. The company is dedicated to creating treatments for patients with infections caused by multidrug-resistant super bacteria, and also has a pipeline of other investigational medicines for cancer and inflammation. The company was established in 2012 and is headquartered in Shanghai City, China.

Headquarters
Building 101, 2, 1-4 Floor, No. 53 Edison Road, China (Shanghai) Pilot Free Trade Zone, Shanghai
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. report to view the information.

Website: http://micurxchina.com

Basic Information
Total Employees:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
August 07, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
10.92%
Purchase this report to view the information.
10.8%
Purchase this report to view the information.
10.49%
Purchase this report to view the information.
5.89%
Purchase this report to view the information.
5.8%
Subsidiaries
Corecase (Beijing) Pharmaceutical Co., Ltd.
100%
Mengke Pharmaceutical Technology (Shanghai) Co., Ltd.
100%
Micurx Pharmaceuticals, Inc.
100%
Company Performance
Financial values in the chart are available after Shanghai Micurx Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
91.1%▲
Total operating revenue
41.83%▲
Operating profit (EBIT)
-81.85%▼
EBITDA
-82.06%▼
Net Profit (Loss) for the Period
-81.86%▼
Total assets
-23.1%▼
Total equity
-36.14%▼
Operating Profit Margin (ROS)
15.73%▲
Net Profit Margin
15.72%▲
Return on Equity (ROE)
-8.94%▼
Debt to Equity Ratio
9.97%▲
Quick Ratio
-11.45%▼
Cash Ratio
-0.72%▼

Similar companies

Shanghai Pharmaceuticals Holding Co.,Ltd
 
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
 
Zjamp Group Co., Ltd.
Beijing Northland Biotech Co.,Ltd.
 
Jiangsu Yahong Meditech Co., Ltd.
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司)
 
Hinova Pharmaceuticals Inc.
Mabwell (Shanghai) Bioscience Co., Ltd. (迈威(上海)生物科技股份有限公司)
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo